Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Intravenous Dexmedetomidine in Attenuation of Hemodynamic Response to Laryngoscopy in Controlled Hypertensive Patients: A Prospective Randomised Double-Blind Study

NCT07557680 is registered in ClinicalTrials.gov with Sindh Institute of Urology and Transplantation as lead sponsor.

NCT NCT07557680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07557680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Intravenous Dexmedetomidine in Attenuation of Hemodynamic Response to Laryngoscopy in Controlled Hypertensive Patients: A Prospective Randomised Double-Blind Study
Lead sponsor
Sindh Institute of Urology and Transplantation
Phase
Phase 3
Overall status
Completed
Start date
January 1, 2025
Completion date
June 30, 2025
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia, hemodynamic response, hypertension